CompoAtlas

PREMENOX

Food supplement declared in France, declaration No 2023-1-227

PREMENOX (Nurilia) is a food supplement declared in France. Status: retiré du marché le 1 April 2024. 3 rules of use apply to its ingredients (limits and warnings).

Brand
Nurilia
Food business operator placing the product on the market
NURIBIOL
Status
Retiré du marché le 1 April 2024
Form
Gélule
Daily dose
2 gélules
Directions for use
prendre deux gélules par jour avec un verre d'eau
Intended populations
Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein, Femmes enceintes, Problèmes de foie, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Ménopause

Declaration 174274, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Vitex agnus-castus L.FruitExtrait sec hydroalcoolique400 mg
Angelica sinensis (Oliv.) DielsRacineExtrait sec aqueux200 mg
Linum usitatissimum L.GraineExtrait sec hydroalcoolique150 mg
Actaea racemosa L.RacineExtrait sec aqueux30 mg
Crocus sativus L.StigmatesAutre extrait sec30 mg
Salvia officinalis L.FeuilleExtrait sec aqueux30 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Bisglycinate de zincZinc25 mg15 mg

Additives

E464

Other ingredients

huile de tournesol

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Usage déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein. L'emploi chez les femmes allaitantesest déconseillé.L'emploi est déconseillé chez les personnes souffrant du foie. Demander l'avis d'un professionnel de santé.L’emploi chez les femmes enceintes et les personnes sous antidépresseurs est déconseillé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Nurilia

Enter to analyse, Shift+Enter for a new line